GEN Exclusives

More »

GEN News Highlights

More »
Feb 28, 2007

Peptisyntha Expands Production Capacity in Brussels.

  • Peptisyntha SA launched the expansion of its pilot-scale capacity for the production of cGMP bulk peptides based on solution phase technology at its production plant in Brussels. The expansion includes an additional pilot HPLC purification unit, an additional pilot freeze-dryer, and an additional pilot plant for the chemical synthesis of peptides. All the new units are scheduled to be fully operational in 2007.

    The current development follows the recent expansion of the solid phase peptide synthesis capacity implemented by Peptisyntha, Inc. in Torrance, CA, which came on stream in 2006. Peptisyntha SA and Peptisyntha Inc. are fully owned subsidiaries of Solvay.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?